Pierachille Santus to Omalizumab
This is a "connection" page, showing publications Pierachille Santus has written about Omalizumab.
Connection Strength
0.312
-
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1643-1646.
Score: 0.162
-
Factors reducing omalizumab response in severe asthma. Eur J Intern Med. 2018 06; 52:78-85.
Score: 0.150